chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician, for GARDASIL, a Pregnancy Registry product, concerning a 25 year old female with no pertinent medical history or allergies who was vaccinated intramuscularly with the first 0.5ml dose of GARDASIL (lot# not reported). There was no concomitant medication. The vaccine was given at a different facility so the physician did not have the specific date for dose 1, however she believes the patient received dose 1 two weeks before she found out she was pregnant. Her LMP was 28-FEB-2009. Unspecified medical attention was sought. Prenatal labs were performed with no results reported. No symptoms reported. Her estimated delivery date is 05-DEC-2009. Information has been received from the physician concerning the 25 year old female with a history of 1 pregnancy and 1 live birth and no birth defect in previous pregnancy. On 30-Jul-2009, ultrasound was performed for organ survey, with normal result. On approximately 1-NOV-2009, the patient underwent abdominal ultrasound, result not provided. On approximately 01-NOV-2009, at 35 weeks gestation, the patient experienced appendicitis and underwent appendectomy. From 01-NOV-2009 to 03-NOV-2009, VICODIN was given, as needed, for post appendectomy treatment. On 25-NOV-2009, at 38 weeks and 4 days gestation, the patient delivered a normal male baby, weighing 3579 grams with no complication during labor. The baby's length 51 cm, head circumference 13.5", apgar score 9/9. Follow-up information has been received from a registered nurse in the physician's office who was able to access the patient's chart. It was reported that the patient was diagnosed with appendicitis and admitted to the hospital and underwent an open appendectomy on 01-NOV-2009. The patient was discharged home on 04-NOV-2009. She was seen for follow-up appointment on 10-NOV-2009, when it was noted that she was still having some pain, but was feeling much better. Her assessment was within normal limits. On 25-NOV-2009, the patient delivered a male neonate via a spontaneous vaginal delivery. The health professional contacted during telephone follow-up could not supply the following information: date of vaccination or lot number. Follow-up information was received from a physician via medical records indication that on 30-NOV-2009 the baby was seen for a newborn check. The baby had breast feeding, using similac formula with iron. The physician's assessment was healthy newborn and continued the current feeding regimen. No further information is available.
Case number PHEH2012US008745 is an initial spontaneous report received from a nurse on 19 Apr 2012. This report refers to four patients whose details were not specified. It was reported that these patients were administered only the MenCYW-135 liquid conjugate vaccine component of MENVEO (batch number: A10124) intramuscularly without being reconstituted with MenA lyophilized conjugate vaccine component on an unspecified date. No adverse reaction was reported following this medication error. No further details were provided.
The patient is a resident of a memory care facility. The facility contacted Walgreens to schedule 2nd doses of Pfizer vaccine for several of their residents. The patient came to the pharmacy and we asked if this was the 2nd dose and when the resident had gotten their first dose. The caregiver said the resident got their first dose at another facility before she came to them in January and this would be the 2nd dose. We asked if they had a vaccination card and the caregiver said no. The caregiver was asked about which dose this would be and when the first one was received multiple times at check-in and immediately prior to administration. The vaccine was administered. The facility called several hours later and said the patient had actually already received a 2nd dose in the hospital so the dose we gave was actually a 3rd dose. The facility said that medical personnel were aware she had already had a second dose but that front desk staff did not know.
A few weeks after the vaccine I developed extreme SOB w/ exertion and a terrible cough causing more SOB. It got so bad that on 5/25 I went to ER (Hospital) where I was admitted for 4 days. A Cardiac Cath was done and daily injections of Lasix were given to get the fluid off. 7/9 a cardio version was scheduled and it worked, but during the night my SOB got worse and my O2 sat went down to 80 causing me to go back into A-Fib. And early in the morning on 7/11 I went back to the ER because the SOB got worse and the cough just wouldn't stop and Pulmonary Edema and CHF were diagnosed at that time. In July I had a consultation with a Pulmonologist who performed a Pulmonary function test. And visited with him last week and he thinks I have Pulmonary Fibrosis.
This report was received from Novartis Pharmaceuticals and was assigned manufacturer report number S2012US00395, concerning a currently 20 year old female patient who on an unspecified date when she was younger, was vaccinated with a dose of MMR II (lot number, dose and route not reported). It was reported that the patient had a life threatening reaction to the vaccine. It was unknown if the patient sought medical attention. At the time of the report the patient's outcome was unknown. This was originally reported by a physician. The event was considered to be immediately life-threatening by the reporter. Additional information has been requested.
Patient received vaccine and several minutes later had a fainting spell in the aisle. I attended to patient, we called 911. The patient was alert and responsive to questions. We had patient lay in recovery position while we monitored and waited for EMS to transport. No problems with airway or breathing, no visible reaction at injecton site. Patient did complain after the shot her arm felt heavy.
Bad body aches and fever- 36 hr. Ibuprofen Sore arm- ice ibuprofen  still a little sore Bad dry eye and mouth- 2 days after shot getting worse. Lots of liquids and lubricating eye drops.
Left arm is extremely swollen / tuffy and  swollen 8.6 centimeters wide and 7.5 cm long; Red, its like welted up; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Left arm is extremely swollen / tuffy and  swollen 8.6 centimeters wide and 7.5 cm long) and ERYTHEMA (Red, its like welted up) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jan-2021, the patient experienced PERIPHERAL SWELLING (Left arm is extremely swollen / tuffy and  swollen 8.6 centimeters wide and 7.5 cm long) and ERYTHEMA (Red, its like welted up). The patient was treated with DIPHENHYDRAMINE ongoing since an unknown date at a dose of UNK dosage form. At the time of the report, PERIPHERAL SWELLING (Left arm is extremely swollen / tuffy and  swollen 8.6 centimeters wide and 7.5 cm long) and ERYTHEMA (Red, its like welted up) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Information has been received via the Merck pregnancy registry, from a nurse practitioner (NP), concerning a 22 year old female patient, who on 09-OCT-2006 was vaccinated with the first dose, 0.5ml, IM, of Gardasil (Lot #653735/0688F), and on 09-DEC-2006 was vaccinated with the second dose, 0.5ml, IM, of Gardasil (Lot #654389/0961F). There was no concomitant medication. The NP reported that the patient is now pregnant; the date of the LMP was 14-DEC-2006, with an estimated date of delivery on 20-Sep-2007. A blood test confirmed the pregnancy. The NP reported that the patient had developed "some bleeding during pregnancy." The patient sought unspecified medical attention. Additional information has been requested. 07/08/2008 Initial and follow up information has been received via the Merck pregnancy registry, from a nurse practitioner (NP) and a nurse, concerning a 22 year old female patient, who on 09-OCT-2006 was vaccinated with the first dose, 0.5ml, IM, of GARDASIL (Lot #653735/0688F), and on 09-DEC-2006 was vaccinated with the second dose, 0.5ml, IM, of GARDASIL (Lot #654389/0961F). There was no concomitant medication. The NP reported that the patient is now pregnant; the date of the LMP/date of gestation was "14-DEC-2006", with an estimated date of delivery on 03-AUG-2007 (previously reported as 20-SEP-2007). A blood test confirmed the pregnancy. The NP reported that the patient had developed "some bleeding during pregnancy". On 20-JUL-2007, the patient gave birth "to a normal healthy baby" (gender not specified), birth weight 7 lb 5 oz, 20 1/2 inches long. No further details were provided. The patient sought unspecified medical attention. Additional information is not expected.
Pt was seen in the Covid vaccine clinic for his second dose of moderna vaccine. Pt stated to this nurse that he typically passes out after receiving a vaccine or blood draw. This RN advised pt to sit in the same chair for his 15 min observation period. At approximately 1642 Pt started slumping over in his chair and was unresponsive to voice. His eyes were open, his skin become very pale and was diaphoretic. This Rn along with several RNs that were near by came to his aid. VS were obtained. At 1644 pt lost consciousness for approximately 15 to 30 seconds, EMS was called at this time (1644). Right before pt woke up he had witnessed convulsions. Upon waking, pt was lip smacking, no emesis at this time. His eyes were open and he was supporting his own weight but was not responding to voice commands. At approximately 1646 pt was alert and responding appropriately, stated that he knew where he was now and he was no longer confused. Pt was given an apple juice which he was able to drink without complications. At 1708 pt was A&O x4, had a steady gait, stated that he felt back to baseline and safe to drive home. Pt declined EMS evaluation and left the clinic.
At about 11pm the night of vaccine (1/6/2021) my arm began to feel sore at injection site. Then 5 am (1/7/2021) my head began to hurt. I then had a fever of 100.7 beginning at 6:45 am (1/7/2021). Throughout the day I had chills and my temp fluctuated between 99.6 and 100.4.
Magnet gets stock at the vaccination site; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Magnet gets stock at the vaccination site) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced LIMB DISCOMFORT (Magnet gets stock at the vaccination site). At the time of the report, LIMB DISCOMFORT (Magnet gets stock at the vaccination site) had resolved.            No treatment medication were provided. No concomitant medication information was provided.   This case was linked to MOD-2021-236783 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 17-Jun-2021: Follow-up information received on 17-JUN-2021 contains non-significant information On 17-Jun-2021: Follow-up information received on 17-JUN-2021 contains non-significant information
Patient received IM injection of vaccine. He sat down for the 15 min observation period. After a couple minutes got up to go to the rest room. He came out of the rest room and stated he got dizzy and fell and hit his head. His head was bleeding. Refused 911 but convinced him to go to the ER down the street from our facility. He reported back after the ER visit that he was fine and told us that he has a history of fainting from injections.
Fever of 102, violent chills and body shakes, extreme headache, body aches.
Pt got a rash on her chest as well as redness and injection site pain/redness. Rash on arms too, lower arms.
Patient reports that after 2nd vaccine she had the following symptoms: H/A, nausea, increased somnolence and vomiting to the point where she called out of work. Reported that symptoms were present after the 1st vaccine, but more severe with the 2nd vaccine.
Acute DVT in left leg Thrombectomy performed on October 5th, 2022 Thrombolysis catheter placed on October 7, removed on October 8
Fatigue (2 hours after injection, lasting until following Monday) Fever (11pm the night of the injection, 101.2 at its highest, fever broke around 5am the following morning but returned Sunday night and hit a high of 100.8) Body aches Chest fluttering (the night of the injection) High heart rate Nausea (the night of the injection)  Swollen lymph nodes in left armpit (Sunday evening) Headache
At 4 minutes post vaccine injection, uncontrollable tremors, nausea, dizziness, shortness of breath/tightness to chest, hyperventilation, extremely cold hands, uncontrollable crying. Symptoms lasting approximately 1-2 minutes.   At 9 minutes post injection - all symptoms repeated lasting for 1-2 minutes.   Admitted to the ED 20 minutes post injection for observation.   No treatment necessary, discharged 2 hrs post injection.
Patient observed swelling of lower lip 8/4/16 AM- came directly to office for evaluation. Lip continued to swell. (R) upper arm minimally swollen, no rash, redness or swelling - Treated with prednisone taper and OTC antihistamine.
My legs filled with fluid, causing weight gain of 2 pounds overnight. I got eczema. I had a slight headache. I contacted a family member who is a doctor and did the following: drank plenty of water, wore compression stockings, cut back on salt, elevated legs when possible. The doctor suspected that it was a histamine release that caused the fluid retention, so he suspects I am allergic to something in the vaccine. I am on Claritin daily (including the days before and after receiving the vaccines).
I started having symptoms of sinus issues with headache, runny nose, fatigue on 5-10-2022. On 5-11, I started running fever up to 100.0 with body aches. I took a home test for Covid on 5-12 and it was positive. I called the doctor on the same day and asked her for treatment. She called in Paxlovid and I took it for 5 days. Then I took another home test on 5-17 and it was negative. I have since taken two more home tests with one faint positive and the second showed negative. I did experience extreme fatigue and soreness at injection site after dose 4 Pfizer. I am reporting my breakthrough case of Covid.
Moderate vertigo, dizziness. Comes and goes. Had the same reaction after my 2nd dose but did not connect the two. At that time, I ended up in the hospital for a day and essentially could not function for most of 3 days.
PATIENT STATED HE WAS GETTING HIS FIRST DOSE OF PFIZER BUT UPON BILLING HIS INSURANCE AFTER THE DOSE WAS GIVEN, IT WAS FOUND BY LOOKING IN THE IMMUNIZATION REGISTERY THAT THE PATIENT HAD ALREADY RECEIVED 2 DOSES OF THE COVID PFIZER SHOT ON 01/21/21 AND 02/11/21 AT ANOTHER FACILITY THEREBY RECEIVING 3 TOTAL DOSES.
swelling and large red hard bump on arm  Sore and hot to touch - symptoms did not start until week after vaccination - as of today swelling has decreased and site is itchy and still red and sore
Initial report received from a nurse on 17 Feb 2010: This patient under the age of 4 years with unknown medical history was inadvertently received S-OIV FLUVIRIN (batch no. 102138P1A), 0.5 ml, IM, on 16 Feb 2010. No adverse effects were noted after vaccine administration.
ADVERSE EVENT UNSPECIFIED; This spontaneous report received from a patient concerned an 82 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced adverse event unspecified. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of adverse event unspecified was not reported. This report was non-serious.
Started menstrual cycle after 4 years of being without one. Heavy bleeding for 13 days
Pregnant and received Moderna; This spontaneous prospective pregnancy case was reported by an other health care professional and describes the occurrence of MATERNAL EXPOSURE BEFORE PREGNANCY (Pregnant and received Moderna) in a 39-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011220A) for COVID-19 vaccination.     The patient's past medical history included Pregnancy (Live, full-term birth) on 26-Sep-2017. Concurrent medical conditions included Fish allergy and Latex allergy. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Allergy, MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.    On 06-Dec-2020 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was in June 2020 and the estimated date of delivery was 21-Mar-2021. On 06-Dec-2020, the patient experienced MATERNAL EXPOSURE BEFORE PREGNANCY (Pregnant and received Moderna). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy. The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. On 06-Dec-2020, MATERNAL EXPOSURE BEFORE PREGNANCY (Pregnant and received Moderna) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient has a prior use of alcohol once a month and stopped in Jan-2020. The estimated date of conception was Jul-2020. The patient received prenatal care. No treatment information was provided.  Case comment: This is a case of product exposure during pregnancy with no associated AEs for this 39-year-old female. Patient will continue to be contacted for further monitoring of AEs during the pregnancy; Reporter's Comments: This is a case of product exposure during pregnancy with no associated AEs for this 39-year-old female. Patient will continue to be contacted for further monitoring of AEs during the pregnancy
My legs feel like they have very bad sunburn. I also have a sensitive to touch area on my leg.
Fatigue/Tired; Fever; Headache; Not hungry; Chills; Nausea; Not feeling well; This is a spontaneous report from a contactable consumer. A 65-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EN5318, expiration date: May2021), via an unspecified route of administration on arm right on 02Feb2021 12:20 PM at single dose for COVID-19 vaccination. The patient medical history included ongoing depression from 2001, Arthritis, preventative for bone disease, anxiety, because Lamotrigine causes her blood sugar to increase all ongoing. The patient concomitant medications included , Aripiprazole (5mg in the morning) from 2017 and ongoing for preventative for Depression, Bupropion hydrochloride (SR 150 mg daily) from an unspecified date and ongoing for preventative for Depression, Calcium(600 mg, takes 2 daily) from 2017 and ongoing for preventative for bone disease, Clonazepam(1mg in the evening) from 2003 and ongoing for Depression and anxiety, D3 (1,000 units takes 2 daily) from 2015 and ongoing for preventative for Depression, Lamotrigine (200 mg daily) from 2015 and ongoing for Depression and anxiety, Meloxicam (15 mg daily) from May2020 and ongoing for preventative for Arthritis, , , Metformin (HCL 500 mg daily) from 2018 and ongoing for Proliferative for depression, Lamotrigine(depression meds) causes her blood sugar to increase. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. On 03Feb2021, the patient experienced tired and fatigue, Headache, Nausea, not feeling well, which is ongoing and experienced Fever, not hungry, Chills from 03Feb2021 to 04Feb2021 with the duration of 1 day. On 04Feb2021, the patient experienced missed work. The patient laboratory test included Body temperature 100.5 degree. The outcome of the events tired and fatigue, Headache, Nausea, not feeling well was Recovering, while other events not hungry, Chills, Fever was Recovered on 04Feb2021.
Moderna COVID-19 Vaccine EUA Itching, swelling, redness and warm to touch - noticed this morning (January 15, 2021) Size 2.5 inches up & down length and 2 inches wide  I experienced these similar injection site reactions 3 days after vaccine injected on January 5, 2021 but they subsided within 24 hours.
pt recv vax 16FEB98  7AM & no rxn until 19FEB98, worsening everyday there after, site area warm, hard, red & spreading down arm;
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. On an unknown date in 2014 (reported as 08-AUG-2014), the patients were vaccinated with (Merck) VARIVAX which was improperly stored, (strength, dose, lot numbers and route were not reported). No adverse effects were reported. Follow up information has been received from the registered nurse who stated that it will take some time to get the (Merck) VARIVAX information (patient identifiers, lot numbers, expiration dates and dates of vaccine administration) together and that she may send the information at a later time. Follow up information has been received from the registered nurse concerning a patient (age range reported as 6-12, units not reported) of unknown gender. On 03-OCT-2014, the patient was vaccinated with a dose of (Merck) VARIVAX which was improperly stored (lot number K005180, expiration date 10-APR-2016; dose number, dose and route were not reported). The reporter stated that this was the information that they could find and provide and anything further would be much too difficult and time consuming due to their record keeping and tracking system. This is one of several reports received from the same reporter. Additional information is not expected because follow up has been obtained.
Joint, (R) arm pain, shoulder to mid forearm. Home - began chilling about 19:00 -> elevated temp 101 through night - unresponsive to ibuprofen, chilling body/skin painful - AM to work - temp 99.3 - resolved by 09:30.
I did not have an adverse reaction to the vaccine but test positive for Covid 19 on 5/17/2022. The infection date was on 5/13/2022. I took a home test for Covid 19 and it was negative. Two days later I knew that wasn't right, I had an appt with my doctor, they did a PCR test and it was positive 5/17. My symptoms where scratchy throat, cough, spiked a fever for about 1 1/2 and sinus congestion for two weeks. My doctor prescribed prednisone for the cough which helped but it never really stopped. I was prescribed a cough pill to help with the cough which seems to be helping.
Varicella vaccine breakthrough. Seen in office on 2-14-06 and diagnosed with varicella. Rash started 2-11-06. No fever. Had approximately 30 lesions-scattered papules and pustules trunk and buttocks. One lesion on buttocks was infected-treated with Augmentin.
no fever, screaming episode for 5 hrs (only consolable for 5min-10mins) 2 days post vax; office visit requested but did not make appt;
Uncontrollable intermittent twitching of muscles in only left side of face that shortly after waking 2 days after the second dose